FIELD: medicine.
SUBSTANCE: invention relates to the compound shown in formula I.
EFFECT: new compound with cerebroprotective activity in the conditions of focal cerebral ischemia has been obtained, which can be used in medicine to correct metabolic disorders in brain tissue with its ischemic lesion.
1 cl, 6 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL N-SULPHANILAMIDE DERIVATIVE OF PYRIMIDIN-4(1H)-ONE, HAVING CEREBROPROTECTIVE ACTIVITY FOR TREATING CHRONIC TRAUMATIC ENCEPHALOPATHY | 2019 |
|
RU2711613C1 |
AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
TETRAPEPTIDE AND PREPARATION, POSSESSING CEREBROPROTECTIVE AND ANTIAMNESTIC ACTIVITIES (VERSIONS) | 2013 |
|
RU2537560C2 |
MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
AGENT POSSESSING ANTIRADICAL, CEREBROPROTECTIVE AND ANTIISCHEMIC PROPERTIES | 2010 |
|
RU2445090C1 |
METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
AGENT WITH NEUROPROTECTIVE ACTIVITY | 2019 |
|
RU2800955C2 |
DRUG FOR IMPROVING BLOOD SUPPLY OF ISCHEMIZED BRAIN | 2019 |
|
RU2747202C2 |
Authors
Dates
2021-12-09—Published
2020-12-25—Filed